rs776645403
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000552810.6(CEP290):c.1078C>T(p.Arg360Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000199 in 1,307,728 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R360R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000552810.6 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEP290 | NM_025114.4 | c.1078C>T | p.Arg360Ter | stop_gained | 13/54 | ENST00000552810.6 | NP_079390.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEP290 | ENST00000552810.6 | c.1078C>T | p.Arg360Ter | stop_gained | 13/54 | 1 | NM_025114.4 | ENSP00000448012 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000264 AC: 4AN: 151440Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000376 AC: 3AN: 79762Hom.: 0 AF XY: 0.0000231 AC XY: 1AN XY: 43218
GnomAD4 exome AF: 0.0000190 AC: 22AN: 1156288Hom.: 0 Cov.: 20 AF XY: 0.0000212 AC XY: 12AN XY: 565940
GnomAD4 genome AF: 0.0000264 AC: 4AN: 151440Hom.: 0 Cov.: 32 AF XY: 0.0000406 AC XY: 3AN XY: 73850
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 27, 2021 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 22355252, 25097241) - |
Pathogenic, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The CEP290 p.R360* variant was identified as a compound heterozygous variant in multiple individuals with Leber congenital amaurosis and retinitis pigmentosa (Yzer_2012_PMID: 22355252; Wang_2014_PMID: 25097241). The variant was identified in dbSNP (ID: rs776645403) and ClinVar (classified as pathogenic by Fulgent Genetics and Invitae). The variant was identified in control databases in 3 of 79762 chromosomes at a frequency of 0.00003761 (Genome Aggregation Database March 6, 2019, v2.1.1). The c.1078C>T variant leads to a premature stop codon at position 360 which is predicted to lead to a truncated or absent protein and loss of function. Loss of function variants of the CEP290 gene are a mechanism of disease in the autosomal recessive conditions: Joubert syndrome, Leber congenital amaurosis, Meckel syndrome, Senior-Loken syndrome, and Bardet-Biedl syndrome. In summary, based on the above information this variant meets our laboratory’s criteria to be classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Feb 06, 2023 | - - |
CEP290-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 05, 2024 | The CEP290 c.1078C>T variant is predicted to result in premature protein termination (p.Arg360*). This variant has been reported along with a second pathogenic CEP290 variant in individuals with autosomal recessive Leber congenital amaurosis and retinitis pigmentosa (see for example, Yzer et al. 2012. PubMed ID: 22355252, patient 15; Wang et al. 2014. PubMed ID: 25097241). To our knowledge, the c.1078C>T variant has not been reported in the homozygous state in any patients. This variant is reported in 0.018% of alleles in individuals of South Asian descent in gnomAD. Nonsense variants in CEP290 are expected to be pathogenic. This variant is interpreted as pathogenic. - |
Leber congenital amaurosis Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Bardet-Biedl syndrome 14 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Feb 07, 2024 | - - |
Meckel-Gruber syndrome;C0431399:Familial aplasia of the vermis;C0687120:Nephronophthisis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 08, 2024 | This sequence change creates a premature translational stop signal (p.Arg360*) in the CEP290 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CEP290 are known to be pathogenic (PMID: 16909394, 17345604, 20690115). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with autosomal recessive Leber congenital amaurosis and autosomal recessive retinitis pigmentosa (PMID: 22355252, 25097241). ClinVar contains an entry for this variant (Variation ID: 530911). For these reasons, this variant has been classified as Pathogenic. - |
Senior-Loken syndrome 6;C1857780:Joubert syndrome 5;C1857821:Leber congenital amaurosis 10;C1970161:Meckel syndrome, type 4;C2673874:Bardet-Biedl syndrome 14 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 20, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at